Natco Pharma Annual Results

FINANCIALS

Select Period:

Particulars ( Rupees In Crores.)	Mar-2022	Mar-2021	Mar-2020	Mar-2019	Mar-2018
Gross Sales	1944.80	2052.10	1,915	2094.50	2,202
Excise Duty	--	--	--	--	17.20
Net Sales	1944.80	2052.10	1,915	2094.50	2184.80
Other Operating Income	--	--	--	--	--
Other Income	99	103.60	107.40	130.20	40.40
Total Income	2043.80	2155.70	2022.40	2224.70	2225.20
Total Expenditure	1681.30	1445.90	1332.40	1299.70	1256.40
PBIDT	362.50	709.80	690	925	968.80
Interest	17.70	13.30	21.50	19.30	15.40
PBDT	344.80	696.50	668.50	905.70	953.40
Depreciation	142.60	116.90	99.80	81	66.20
Minority Interest Before NP	--	--	--	--	--
Tax	47.80	147.80	131.10	188.30	219.90
Deferred Tax	(15.60)	(10.60)	(20.50)	(6)	(27.90)
Reported Profit After Tax	170	442.40	458.10	642.40	695.20
Minority Interest After NP	--	1.50	(2.70)	(2)	(1)
Net Profit after Minority Interest	170	440.90	460.80	644.40	696.20
Extra-ordinary Items	--	--	--	--	--
Adjusted Profit After Extra-ordinary item	170	440.90	460.80	644.40	696.20
EPS (Unit Curr.)	9.32	24.20	25.33	34.98	39.26
Book Value (Unit Curr.)	--	--	--	--	--
Dividend (%)	225	262.50	337.50	312.50	412.50
Equity	36.50	36.50	36.40	36.50	36.90
Public Shareholding (Number)	--	--	--	--	--
Public Shareholding (%)	--	--	--	--	--
Pledged/Encumbered - No. of Shares	--	--	--	--	--
Pledged/Encumbered - % in Total Promoters Holding	--	--	--	--	--
Pledged/Encumbered - % in Total Equity	--	--	--	--	--
Non Encumbered - No. of Shares	--	--	--	--	--
Non Encumbered - % in Total Promoters Holding	--	--	--	--	--
Non Encumbered - % in Total Equity	--	--	--	--	--
PBIDTM(%)	18.64	34.59	36.03	44.16	44.34
PBDTM(%)	17.73	33.94	34.91	43.24	43.64
PATM(%)	8.74	21.56	23.92	30.67	31.82

QuickLinks for Natco Pharma Ltd.